Viking Therapeutics US92686J1060
Key Clinical Developments Drive Momentum
A Steep Single-Day Decline
BioNTech US09075V1026
A Landmark in Breast Cancer Treatment
Key Drug Candidate Fails Phase III Trial
Clinical Trial Setback Casts Shadow Over Bayer’s Strong Quarterly ...